Back
GH Research PLC Vs. Iterum Therapeutics PLC Industry Stock Comparison
Sell
18
GHRS
GH Research PLC
Last Price:
7.83
Seasonality Move:
-19.66%
Sell
42
ITRM
Iterum Therapeutics PLC
Last Price:
1.10
Seasonality Move:
6.4%
Sell
18
GH Research PLC (GHRS)
is a Sell
Is GH Research PLC a Buy, Sell or Hold?
- The current GH Research PLC [GHRS] share price is $7.88. The Score for GHRS is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- GHRS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Iterum Therapeutics PLC (ITRM)
is a Sell
Is Iterum Therapeutics PLC a Buy, Sell or Hold?
- The current Iterum Therapeutics PLC [ITRM] share price is $1.09. The Score for ITRM is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- ITRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GHRS Stock Price Chart
What is GH Research PLC's stock price today?
-
The GH Research PLC share price today is $7.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GHRS is experiencing selling pressure, which indicates risk of future bearish movement.
ITRM Stock Price Chart
What is Iterum Therapeutics PLC's stock price today?
-
The Iterum Therapeutics PLC share price today is $1.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITRM is experiencing slight selling pressure.
GHRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.8 | Sell |
| Relative Strength Index (14 RSI): | 30.1 | Sell |
| Chaikin Money Flow: | -19670 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.31 - 10.93) | Sell |
| Bollinger Bands (100): | (9.97 - 12.91) | Sell |
ITRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 46.65 | Sell |
| Chaikin Money Flow: | -28749 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.06 - 1.24) | Sell |
| Bollinger Bands (100): | (1.11 - 1.45) | Sell |
GHRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.19 | Sell |
| 20-day SMA: | 9.45 | Sell |
| 50-day SMA: | 10.57 | Sell |
| 200-day SMA: | 9.77 | Sell |
| 8-day EMA: | 8.31 | Sell |
| 20-day EMA: | 9.08 | Sell |
| 50-day EMA: | 10.15 | Sell |
| 200-day EMA: | 10.38 | Sell |
ITRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.07 | Buy |
| 20-day SMA: | 1.12 | Sell |
| 50-day SMA: | 1.21 | Sell |
| 200-day SMA: | 1.47 | Sell |
| 8-day EMA: | 1.08 | Buy |
| 20-day EMA: | 1.11 | Sell |
| 50-day EMA: | 1.18 | Sell |
| 200-day EMA: | 1.33 | Sell |
GH Research PLC Earnings Growth & GHRS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.31 per share.
Iterum Therapeutics PLC Earnings Growth & ITRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.53 per share, and an increase next year of $0.21 per share.
GH Research PLC Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Iterum Therapeutics PLC Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||